Proking may be available in the countries listed below.
Clobutinol hydrochloride (a derivative of Clobutinol) is reported as an ingredient of Proking in the following countries:
International Drug Name Search
Sapofen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Sapofen in the following countries:
Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Sapofen in the following countries:
International Drug Name Search
Carpilo may be available in the countries listed below.
Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Carpilo in the following countries:
Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Carpilo in the following countries:
International Drug Name Search
In the US, Carnitor (levocarnitine systemic) is a member of the drug class nutraceutical products and is used to treat Carnitine Deficiency and Peripheral Neuropathy.
US matches:
UK matches:
Levocarnitine is reported as an ingredient of Carnitor in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Crofed may be available in the countries listed below.
Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Crofed in the following countries:
Triprolidine hydrochloride monohydrate (a derivative of Triprolidine) is reported as an ingredient of Crofed in the following countries:
International Drug Name Search
Benylin Descongestivo may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Benylin Descongestivo in the following countries:
Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Benylin Descongestivo in the following countries:
International Drug Name Search
Synrelina may be available in the countries listed below.
Nafarelin acetate (a derivative of Nafarelin) is reported as an ingredient of Synrelina in the following countries:
International Drug Name Search
Carnidose may be available in the countries listed below.
Levocarnitine is reported as an ingredient of Carnidose in the following countries:
International Drug Name Search
Generic Name: demecarium bromide ophthalmic (deh meh KARE ee um)
Brand Names: Humorsol Ocumeter
Demecarium bromide ophthalmic reduces pressure in the eye by increasing the amount of fluid that drains from the eye. Demecarium bromide ophthalmic also causes the pupil to become smaller and reduces its response to light or dark conditions.
Demecarium bromide ophthalmic is used to treat glaucoma by lowering the pressure inside the eye. Demecarium bromide ophthalmic is also used for other conditions that require increased fluid outflow from the eye, after surgical iridectomy, and for certain eye disorders involving eye accommodation (focusing).
Demecarium bromide ophthalmic may also be used for purposes other than those listed in this medication guide.
Contact your doctor immediately if you notice any decrease in vision or an increase in "floaters" in your visual field. Rarely, demecarium bromide ophthalmic may cause retinal detachment. Retinal detachment can lead to blind spots, floaters in the visual field, and even blindness. Your doctor will want to check your retina before you use this medication to determine if you have an increased risk of retinal detachment.
Apply light pressure to the inside corner of the eye (near the nose) after each application to prevent the medicine from draining down the tear duct.
Rarely, demecarium bromide ophthalmic may cause retinal detachment. Tell your doctor if you have any type of retinal disease, if you have had a retinal tear, if you are nearsighted, or if you have had cataract surgery. These conditions may increase the risk of retinal detachment.
Before using this medication, tell your doctor if you
have heart failure,
have high or low blood pressure,
have ever had a heart attack,
have asthma,
have a stomach ulcer or stomach spasms,
have epilepsy,
have hyperthyroidism (an overactive thyroid),
have blockage of your urinary tract or difficulty urinating, or
have Parkinson's disease.
You may not be able to use demecarium bromide ophthalmic, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
If you wear contact lenses, remove them before applying demecarium bromide ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication.
Use demecarium bromide ophthalmic eye drops exactly as directed by your doctor. If you do not understand the instructions, ask your doctor, pharmacist, or nurse to explain them to you.
If you wear contact lenses, remove them before applying demecarium bromide ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication.
To apply the eye drops:
Tilt the head back slightly and pull down on the lower eyelid. Position the dropper above the eye. Look up and away from the dropper. Squeeze out a drop and close the eye. Apply gentle pressure to the inside corner of the eye (near the nose) for about 1 minute to prevent the liquid from draining down the tear duct. If you are using more than one drop in the same eye, repeat the process with about 5 minutes between drops. If you are using drops in both eyes, repeat the process in the other eye.
Apply the missed dose as soon as you remember. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.
Symptoms of a demecarium bromide ophthalmic overdose may include sweating, nausea, vomiting, diarrhea, watering mouth, tearing eyes, fainting, difficulty breathing, and an irregular heartbeat.
If you wear contact lenses, remove them before applying demecarium bromide ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication.
Do not use other eye medications during treatment with demecarium bromide ophthalmic except under the direction of your doctor.
Contact your doctor immediately if you notice any decrease in vision or an increase in "floaters" in your visual field. Rarely, demecarium bromide ophthalmic may cause retinal detachment. Retinal detachment can lead to blind spots, floaters in the visual field, and even blindness. Your doctor will want to check your retina before you use this medication to determine if you have an increased risk of retinal detachment.
an allergic reaction (shortness of breath; closing of the throat; swelling of the lips, face, or tongue; or hives);
abdominal cramps or diarrhea;
watering mouth;
excessive sweating;
urinary incontinence;
muscle weakness;
difficulty breathing; or
an irregular heart beat.
Other, less serious side effects may be more likely to occur. Continue to use demecarium bromide ophthalmic and talk to your doctor if you experience
burning, stinging, red, or tearing eyes;
eyelid muscle twitches;
headache or brow ache; or
decreased vision in poor light.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Do not use other eye medications during treatment with demecarium bromide ophthalmic except under the direction of your doctor.
Organophosphates may increase the effects of demecarium bromide ophthalmic. If you are a gardener, an organophosphate plant or warehouse worker, or a farmer, you may be exposed to organophosphates. Follow the directions of your doctor and workplace safety guides regarding respiratory masks and the washing and changing of clothes.
Drugs other than those listed here may also interact with demecarium bromide ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.
Demecarium bromide ophthalmic is available with a prescription under the brand name Humorsol in 0.125% and in 0.25% solutions. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.
Azatioprina Rontag may be available in the countries listed below.
Azathioprine is reported as an ingredient of Azatioprina Rontag in the following countries:
International Drug Name Search
Lévisole may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Levamisole is reported as an ingredient of Lévisole in the following countries:
Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Lévisole in the following countries:
International Drug Name Search
Bivicetyl may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Bivicetyl in the following countries:
International Drug Name Search
Apiguard may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Thymol is reported as an ingredient of Apiguard in the following countries:
International Drug Name Search
Treating certain types of seizures in patients with epilepsy. It may be used alone or in combination with other medicines. It may also be used for other conditions as determined by your doctor.
Oxcarbazepine is an anticonvulsant. It works by slowing abnormal nerve impulses in the brain.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Oxcarbazepine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Oxcarbazepine. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxcarbazepine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Oxcarbazepine as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Oxcarbazepine.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; headache; indigestion; mild stomach pain; nausea; tiredness; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, eyes, face, lips, or tongue; unusual hoarseness); blood in the stool; chest pain; decreased coordination; decreased urination; difficulty concentrating or speaking; double vision, changes in vision, or involuntary eye movement; dulled sense of touch; fast, slow, or irregular heartbeat; fever, chills, or sore throat; joint or muscle pain, swelling, or weakness; new or worsening mental or mood changes (eg, depression, agitation, anxiety, panic attacks, aggressiveness, impulsiveness, behavior changes, suicidal thoughts or actions); new or worsening seizures; nosebleed; painful sores in the mouth or around the eyes; red, swollen, blistered, or peeling skin; severe or persistent stomach pain; shortness of breath; swollen lymph nodes; symptoms of liver problems (eg, dark urine, loss of appetite, pale stools, yellowing of the skin or eyes); symptoms of low sodium levels (nausea, general body discomfort, headache, lack of energy, confusion, decreased consciousness, increased frequency or severity of seizures); tremor; trouble sleeping; trouble walking; uncontrolled muscle movements; unusual bruising or bleeding; unusual tiredness or weakness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Oxcarbazepine side effects (in more detail)
Contact 1- 800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Oxcarbazepine at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oxcarbazepine out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Oxcarbazepine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Disopyramide Sustained-Release Capsules sometimes produces new irregular heartbeats (arrhythmias). Therefore, it should be used in carefully selected patients. Consult your doctor or pharmacist for more information.
Correcting or preventing various types of life-threatening irregular heartbeats and heart rhythm disturbances.
Disopyramide Sustained-Release Capsules are an antiarrhythmic. It works by stabilizing the heart rhythm in conditions in which the heart is beating too fast or in an irregular rhythm (antiarrhythmic effect).
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Disopyramide Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Disopyramide Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Disopyramide Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Disopyramide Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Disopyramide Sustained-Release Capsules.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Aches or pain; bloating; blurred vision; constipation; difficulty urinating; dizziness; dryness of the eyes, mouth, nose, or throat; fatigue; frequent and urgent urination; gas; general body discomfort; headache; muscle weakness; nausea; tiredness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; fainting; fast or slow heartbeat; fever; lightheadedness; heart rhythm problems; severe difficulty urinating; shortness of breath; sore throat; swelling.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Disopyramide side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include difficulty breathing; change in heart rhythm; loss of consciousness.
Store Disopyramide Sustained-Release Capsules at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Keep Disopyramide Sustained-Release Capsules out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Disopyramide Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Chlorsuccillin may be available in the countries listed below.
Suxamethonium Chloride is reported as an ingredient of Chlorsuccillin in the following countries:
International Drug Name Search
FML Forte Liquifilm is a brand name of fluorometholone ophthalmic, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of FML Forte Liquifilm available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of FML Forte Liquifilm. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with FML Forte Liquifilm.
Evothyl may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Evothyl in the following countries:
International Drug Name Search
Kezole may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Kezole in the following countries:
International Drug Name Search
Cefuracet may be available in the countries listed below.
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cefuracet in the following countries:
International Drug Name Search
Ciprofloxacin Heumann may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacin Heumann in the following countries:
International Drug Name Search
Genbexil may be available in the countries listed below.
Gentamicin is reported as an ingredient of Genbexil in the following countries:
International Drug Name Search
Amlodipina Hexal may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipina Hexal in the following countries:
International Drug Name Search
In the US, Pontocaine (tetracaine topical) is a member of the drug class topical anesthetics and is used to treat Allergic Urticaria, Cold Sores, Local Anesthesia, Skin Rash and Urticaria.
US matches:
Tetracaine hydrochloride (a derivative of Tetracaine) is reported as an ingredient of Pontocaine in the following countries:
International Drug Name Search
Vitaminum B6 may be available in the countries listed below.
Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Vitaminum B6 in the following countries:
International Drug Name Search
Masticlav may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Masticlav in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Masticlav in the following countries:
International Drug Name Search
Propranolol Stada may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Stada in the following countries:
International Drug Name Search
Cefonicid ratiopharm may be available in the countries listed below.
Cefonicid disodium salt (a derivative of Cefonicid) is reported as an ingredient of Cefonicid ratiopharm in the following countries:
International Drug Name Search
Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.
Brompheniramine/Pseudoephedrine Suspension is an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Brompheniramine/Pseudoephedrine Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Brompheniramine/Pseudoephedrine Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine/Pseudoephedrine Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Brompheniramine/Pseudoephedrine Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Brompheniramine/Pseudoephedrine Suspension.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Brompheniramine/Pseudoephedrine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.
Store Brompheniramine/Pseudoephedrine Suspension at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Brompheniramine/Pseudoephedrine Suspension out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Brompheniramine/Pseudoephedrine Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Sodate Ointment may be available in the countries listed below.
Fusidic Acid is reported as an ingredient of Sodate Ointment in the following countries:
International Drug Name Search
Acido Alendronico Ratiopharm may be available in the countries listed below.
Alendronic Acid is reported as an ingredient of Acido Alendronico Ratiopharm in the following countries:
International Drug Name Search
| Table 1. Ranitidine Pharmacokinetics in Pediatric Patients Following Oral Dosing | ||||
| Population (age) | n | Dosage Form (dose) | Cmax (ng/mL) | Tmax (hours) |
| Gastric or duodenal ulcer (3.5 to 16 years) | 12 | Tablets (1 to 2 mg/kg) | 54 to 492 | 2.0 |
| Otherwise healthy requiring ranitidine (0.7 to 14 years, Single dose) | 10 | Syrup (2 mg/kg) | 244 | 1.61 |
| Otherwise healthy requiring ranitidine (0.7 to 14 years, Multiple dose) | 10 | Syrup (2 mg/kg) | 320 | 1.66 |
| Table 2. Effect of Oral Ranitidine on Gastric Acid Secretion | |||||
| Time After Dose, hours | % Inhibition of Gastric Acid Output by Dose, mg | ||||
| 75-80 | 100 | 150 | 200 | ||
| Basal | Up to 4 | 99 | 95 | ||
| Nocturnal | Up to 13 | 95 | 96 | 92 | |
| Betazole | Up to 3 | 97 | 99 | ||
| Pentagastin | Up to 5 | 58 | 72 | 72 | 80 |
| Meal | Up to 3 | 73 | 79 | 95 | |
| Table 3. Duodenal Ulcer Patient Healing Rates | ||||
| Ranitidine* | Placebo* | |||
| Number Entered | Healed / Evaluable | Number Entered | Healed / Evaluable | |
| Outpatients | 195 | 69/182 (38%) † | 188 | 31/164 (19%) |
| Week 2 | ||||
| Week 4 | 137/187 (73%) † | 76/168 (45%) | ||
| Table 4. Mean Daily Doses of Antacid | ||
| Ulcer Healed | Ulcer Not Healed | |
| Ranitidine | 0.06 | 0.71 |
| Placebo | 0.71 | 1.43 |
| Table 5. Duodenal Ulcer Prevalence | |||||
| Double-Blind, Multicenter, Placebo-Controlled Trials | |||||
| Multicenter Trial | Drug | Duodenal Ulcer Prevalence | No. Of Patients | ||
| 0-4 Months | 0-8 Months | 0-12 Months | |||
| USA | RAN | 20%* | 24%* | 35%* | 138 |
| PLC | 44% | 54% | 59% | 139 | |
| Foreign | RAN | 12%* | 21%* | 28%* | 174 |
| PLC | 56% | 64% | 68% | 165 | |
| Table 6. Gastric Ulcer Patient Healing Rates | ||||
| Ranitidine* | Placebo* | |||
| Number Entered | Healed / Evaluable | Number Entered | Healed / Evaluable | |
| Outpatients | 92 | 16/83 (19%) | 94 | 10/83 (12%) |
| Week 2 | ||||
| Week 6 | 50/73 (68%)† | 35/69 (51%) | ||
| Table 7. Erosive Esophagitis Patient Healing Rates | ||
| Healed / Evaluable | ||
| Placebo* n=229 | Ranitidine HCl 150 mg 4 times daily* n=215 | |
| Week 4 | 43/198 (22%) | 96/206 (47%) † |
| Week 8 | 63/176 (36%) | 142/200 (71%) † |
| Week 12 | 92/159 (58%) | 162/192 (84%) † |
| RANITIDINE ranitidine hydrochloride tablet | ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
